All treatments
Treatment
Tecentriq 840 mg concentrate for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase II, Single-Arm Study of Atezolizumab in Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer who have not Progressed after Platinum-Based Concurrent Chemoradiation
This study is testing a new treatment called Tecentriq for a type of lung cancer that has started to grow but hasn't spread widely. It aims to see if Tecentriq can help keep the cancer from growing for a longer time after standard treatments.
For: Non-Small Cell Lung Cancer (NSCLC)Slovenia · Spain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
PANOVA-4: Pilot, Single arm Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
This study, called PANOVA-4, is looking at a new treatment combination for a type of advanced pancreatic cancer. It combines gentle electrical fields called TTFields with existing medications (Atezolizumab, Gemcitabine, and Nab-Paclitaxel) to see how well it controls the disease and helps people live longer.
For: Metastatic pancreatic ductal adenocarcinoma (mPDAC)Spain · Germany · Czechia